AbbVie (NYSE:ABBV) has agreed to acquire Capstan Therapeutics to expand its work in in vivo CAR-T cell therapy. The company ...

AbbVie Inc. stays a Strong Buy after a Q4 2025 earnings beat led by HUMIRA, plus growth in immunology and neuroscience. Click ...

The government website is meant to connect Americans with drug companies to buy prescriptions directly with their own money.

CVS Health® (NYSE: CVS) today announced new steps to further help customers expand adoption of lower-cost biosimilar medications. Effective April 1, 2026, CVS Caremark will begin offering osteoporosis ...

CVS Health Inc. CVS on Thursday said it is taking additional steps to lower prescription drug costs by expanding access to biosimilar medications, announcing new formulary changes that will take ...

Investors pummeled AbbVie stock Wednesday after the company delivered a fourth-quarter sales beat, thanks to Humira.

AbbVie Inc. Q4 2025 shows SKYRIZI/RINVOQ strength but diversification risks and M&A reliance. Click here to read this earnings analysis of ABBV stock.

Feb 5 () - CVS Health said on Thursday it would swap out Amgen and Eli Lilly's bone disease treatments for ​lower-cost ...

President Trump launched TrumpRx.gov, a website designed to help Americans purchase prescription drugs directly from manufacturers or pharmacies. While the site aims to lower costs, experts warn many ...

Cigna Corporation (NYSE:CI) Q4 2025 Earnings Call Transcript February 5, 2026 Cigna Corporation beats earnings expectations.

The legislation will impose new restrictions on pharmacy benefit managers, giant companies like CVS Caremark, Optum Rx and ...

AbbVie and Medtronic have a long history of raising their dividends and continue to have healthy free cash flow for further dividend growth.